Invesco Biotechnology & Genome ETF Rating $64.15 -0.70 (-1.08%) As of 03/28/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.69Holdings in PBE have an aggregate rating of Moderate Buy based on 438 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).PBE Aggregate Price Target$64.15High Prediction$64.15Average Prediction$64.15Low Prediction$64.15Holdings in PBE have an aggregate price target of $64.15 and a range of $64.15 to $64.15 covering 30 companies (99.9% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.96%NBIXNeurocrine Biosciences$113.16-0.7%4.9221 of 5 stars2.83$165.38 46.1%23Positive News4.95%AMGNAmgen$306.95+0.4%4.4251 of 5 stars2.48$314.04 2.3%23Analyst UpgradePositive News4.91%BIIBBiogen$138.37-1.4%4.8988 of 5 stars2.43$213.33 54.2%30Positive News4.90%NTRANatera$143.94-2.9%3.1106 of 5 stars3.00$178.12 23.7%16Short Interest ↑Positive News4.76%GILDGilead Sciences$111.79+0.6%4.5794 of 5 stars2.72$105.12 -6.0%29Positive News4.57%ILMNIllumina$80.00-2.8%4.772 of 5 stars2.48$140.90 76.1%21Positive News4.54%REGNRegeneron Pharmaceuticals$637.36+0.2%4.8124 of 5 stars2.76$973.13 52.7%25Short Interest ↑Positive News4.45%UTHRUnited Therapeutics$306.97-0.3%4.9334 of 5 stars2.67$388.25 26.5%12Short Interest ↓Positive News4.06%PTGXProtagonist Therapeutics$48.88-1.1%3.5959 of 5 stars3.00$62.56 28.0%9Analyst ForecastPositive News3.96%TGTXTG Therapeutics$39.86-0.8%3.0261 of 5 stars2.83$40.67 2.0%6Positive News3.36%CPRXCatalyst Pharmaceuticals$24.69-0.6%4.8173 of 5 stars3.13$32.29 30.8%83.07%PTCTPTC Therapeutics$54.24-1.4%3.2706 of 5 stars2.53$64.00 18.0%152.99%HALOHalozyme Therapeutics$63.84-1.0%4.2631 of 5 stars2.60$62.78 -1.7%10Positive News2.88%COLLCollegium Pharmaceutical$29.71+0.5%4.052 of 5 stars2.80$43.60 46.8%52.83%BPMCBlueprint Medicines$88.72-1.1%2.7952 of 5 stars2.70$124.95 40.8%23Positive News2.80%DVAXDynavax Technologies$13.68-0.3%4.2892 of 5 stars2.33$21.50 57.2%3Positive News2.77%EXELExelixis$36.70-0.4%4.5278 of 5 stars2.50$37.59 2.4%20Upcoming EarningsAnalyst RevisionPositive News2.74%BMRNBioMarin Pharmaceutical$71.44-1.9%4.9228 of 5 stars2.71$94.00 31.6%24Positive News2.72%QGENQiagen$39.86+0.5%3.4317 of 5 stars2.30$47.71 19.7%10Short Interest ↑2.71%RPRXRoyalty Pharma$31.37-0.9%4.8322 of 5 stars3.00$41.60 32.6%6Analyst ForecastPositive News2.68%VCYTVeracyte$30.12-3.2%4.464 of 5 stars2.70$43.40 44.1%10Positive News2.63%BCRXBioCryst Pharmaceuticals$7.86+0.4%4.2969 of 5 stars2.86$15.57 98.1%7Short Interest ↑Positive News2.58%TECHBio-Techne$58.73-2.0%4.8627 of 5 stars2.56$81.25 38.3%9Short Interest ↑Positive News2.54%CDNACareDx$17.96-2.1%3.4034 of 5 stars2.57$31.83 77.2%7Positive News2.54%EXASExact Sciences$43.66-3.0%4.4953 of 5 stars2.90$70.26 60.9%21Analyst ForecastPositive News2.51%MNKDMannKind$5.03-1.4%2.4965 of 5 stars3.13$9.21 83.2%82.46%ACADACADIA Pharmaceuticals$17.07-0.7%4.1447 of 5 stars2.50$23.93 40.2%162.43%XNCRXencor$11.23-2.4%3.4434 of 5 stars3.13$34.38 206.1%82.30%MYGNMyriad Genetics$8.88-3.7%4.0399 of 5 stars2.20$21.89 146.5%152.29%INCYIncyte$60.60-0.1%4.6928 of 5 stars2.21$74.88 23.6%19Positive News This page (NYSEARCA:PBE) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PBE Stock Free PBE Stock Alerts